Cocrystal Pharma, Inc. Earnings Per Share Diluted

Quick Answer

Cocrystal Pharma, Inc. reported Earnings Per Share Diluted of $0.78 (loss) per share for the year ending 2025.

  • Cocrystal Pharma, Inc. showed an increase of +54.7% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Cocrystal Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2013: $0.02 (loss) per share | Q2 2013: $0.02 (loss) per share | Q3 2013: $0.02 (loss) per share | Q1 2014: $0.00 per share | Q2 2014: $0.01 per share | Q3 2014: $0.01 (loss) per share | Q1 2015: $0.04 (loss) per share | Q2 2015: $0.01 (loss) per share | Q3 2015: $0.01 (loss) per share | Q4 2015: $0.05 (loss) per share | Q1 2016: $0.17 (loss) per share | Q2 2016: $0.14 (loss) per share | Q3 2016: $0.03 (loss) per share | Q4 2016: $3.06 (loss) per share | Q1 2017: $0.11 (loss) per share | Q2 2017: $0.09 (loss) per share | Q3 2017: $0.08 (loss) per share | Q4 2017: $0.20 per share | Q1 2018: $0.06 (loss) per share | Q2 2018: $0.05 (loss) per share | Q3 2018: $0.06 (loss) per share | Q2 2022: $3.00 (loss) per share | Q3 2022: $0.70 (loss) per share | Q1 2023: $0.64 (loss) per share | Q2 2023: $0.41 (loss) per share | Q3 2023: $0.41 (loss) per share | Q1 2024: $0.39 (loss) per share | Q2 2024: $0.53 (loss) per share | Q3 2024: $0.49 (loss) per share | Q1 2025: $0.23 (loss) per share | Q2 2025: $0.20 (loss) per share | Q3 2025: $0.19 (loss) per share.
  • Over the full 9 years of available data (2013 to 2025), Cocrystal Pharma, Inc.'s Earnings Per Share Diluted has declined by 1,014.3%.
  • Historical annual values: Fiscal year 2025: $0.78 (loss) per share | Fiscal year 2024: $1.72 (loss) per share | Fiscal year 2023: $1.87 (loss) per share | Fiscal year 2022: $4.77 (loss) per share | Fiscal year 2017: $0.03 (loss) per share | Fiscal year 2016: $3.30 (loss) per share | Fiscal year 2015: $2.40 (loss) per share | Fiscal year 2014: $0.01 (loss) per share | Fiscal year 2013: $0.07 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: